Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Drug–diagnostic commercialization and access at Biomarkers Europe 2026
Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website
10 organizations at Biomarkers Europe 2026 present work in drug–diagnostic commercialization & access: 4 academic, government and non-profit bodies, 3 drug developers and 3 technology and service providers. Between them they bring 24 presentations to the program. Most represented: Novartis, AbbVie and Barts Cancer Institute, Queen Mary University of London. As of Oct 8, 2026.
Format
Top represented
Showing 1–10 of 10 organizations
| Organization | Biomarkers Europe 2026 Attendance |
|---|---|
Novartis Basel, Switzerland | |
Swiss pharmaceutical company with marketed medicines in oncology, immunology, neuroscience and cardiovascular disease. | Talk Tue Oct 13 9:15am–9:40am Precision Medicine Beyond the Hype: Delivering Real Clinical Impact Drug–diagnostic commercialization & access Panel Tue Oct 13 12:40pm–1:30pm Application And Integration Of Proteomic Biomarkers In Precision Medicine Genomics, proteomics and multi-omicsBiomarker discovery & translation Talk Tue Oct 13 2:30pm–2:55pm Spatial Autoimmunity - Challenges and Opportunities in Salivary Glands Digital pathology & spatial biomarkers Talk Tue Oct 13 2:55pm–3:20pm Translational Biomarkers For Evaluating Biologic Drug Efficacy Biomarker discovery & translation Talk Tue Oct 13 3:20pm–3:45pm Leveraging UK Biobank to Derive Proteomic Signatures Representative of Disease Biology of Dermatological Indications Genomics, proteomics and multi-omics Talk Wed Oct 14 9:10am–9:35am Digital Health Technology Adoption In Clinical Development Multimodal & AI-enabled precision medicineDrug–diagnostic commercialization & access Panel Wed Oct 14 1:00pm–1:30pm Biomarker Strategies In Neurodegenerative Therapeutics Biomarker discovery & translation Panel Wed Oct 14 3:15pm–4:05pm AI-Enabled Clinical Trial Innovation - From Biomarker Data To Decision Multimodal & AI-enabled precision medicine |
AbbVie North Chicago, IL | |
Global biopharmaceutical company with marketed medicines in immunology, oncology, neuroscience and aesthetics. | Talk Tue Oct 13 9:15am–9:40am A Regulatory Perspective on the Expanding Reach of Personalized Medicine Clinical & companion diagnostic development Panel Tue Oct 13 12:40pm–1:30pm IVDR Regulations & Their Impact Clinical & companion diagnostic development Panel Wed Oct 14 1:00pm–1:30pm From Silos To Alliances – Rethinking Collaboration In Precision Medicine Drug–diagnostic commercialization & access |
Cancer research institute of Queen Mary University of London working on early detection, tumour biology and clinical trials. | Panel Tue Oct 13 12:40pm–1:30pm Navigating The Multi-Omics Investment Landscape: How Investors See The Future Of The Field Genomics, proteomics and multi-omicsDrug–diagnostic commercialization & access Talk Tue Oct 13 2:55pm–3:20pm A Translational Journey To Pancreatic Cancer Detection Biomarker discovery & translation |
Cancer Research UK London, UK | |
UK cancer charity funding research into cancer prevention, early diagnosis and treatment. | Panel Tue Oct 13 12:40pm–1:30pm Application And Integration Of Proteomic Biomarkers In Precision Medicine Genomics, proteomics and multi-omicsBiomarker discovery & translation Panel Wed Oct 14 1:00pm–1:30pm From Silos To Alliances – Rethinking Collaboration In Precision Medicine Drug–diagnostic commercialization & access |
Flanders Investment & Trade Brussels, Belgium | |
Flemish government agency promoting international trade and foreign investment in Flanders, Belgium. | Panel Tue Oct 13 12:40pm–1:30pm Navigating The Multi-Omics Investment Landscape: How Investors See The Future Of The Field Genomics, proteomics and multi-omicsDrug–diagnostic commercialization & access Panel Wed Oct 14 1:00pm–1:30pm From Silos To Alliances – Rethinking Collaboration In Precision Medicine Drug–diagnostic commercialization & access |
Swiss healthcare venture studio building programs and partnerships to bring health innovations to market. | Panel Tue Oct 13 12:40pm–1:30pm Navigating The Multi-Omics Investment Landscape: How Investors See The Future Of The Field Genomics, proteomics and multi-omicsDrug–diagnostic commercialization & access Talk Wed Oct 14 7:55am–8:15am Breakfast Session: Investing in Precision Medicine: The Founder & Investor Perspective Drug–diagnostic commercialization & access |
Step Pharma Saint-Genis-Pouilly, France | |
Clinical-stage biotech developing CTPS1 inhibitors, led by oral dencatistat, for lymphomas and solid tumours. | Panel Tue Oct 13 1:05pm–1:30pm Translating Biomarkers From Discovery To Clinical Use Biomarker discovery & translation Panel Wed Oct 14 1:00pm–1:30pm From Silos To Alliances – Rethinking Collaboration In Precision Medicine Drug–diagnostic commercialization & access |
University of Exeter Exeter, UK | ○Network & Programme Sponsor |
UK university whose ISO 9001-certified research labs offer contract services to industry, including biomarker discovery, imaging and microbiology. | Panel Wed Oct 14 1:00pm–1:30pm From Silos To Alliances – Rethinking Collaboration In Precision Medicine Drug–diagnostic commercialization & access |
QB Quant Biomarkers Basel, Switzerland | |
Data-driven biomarker analytics company set up by Deep Knowledge Group, assessing biomarkers of human ageing with assays and AI models. | Panel Tue Oct 13 12:40pm–1:30pm Navigating The Multi-Omics Investment Landscape: How Investors See The Future Of The Field Genomics, proteomics and multi-omicsDrug–diagnostic commercialization & access |
Healthcare marketing and communications agency using data and AI analytics to help pharma companies bring medicines to market. | Talk Wed Oct 14 10:20am–10:25am Data & AI Zone Presentation - Invisible Influence: The New Visibility Challenge for Pharma Drug–diagnostic commercialization & accessMultimodal & AI-enabled precision medicine |
Instantly find 20 buyers in drug–diagnostic commercialization & access
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Biomarkers Europe 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction